User profiles for A. M. Spivak
Adam M. Spivak, MDUniversity of Utah School of Medicine Verified email at hsc.utah.edu Cited by 3600 |
Urinary tract infections: current and emerging management strategies
Acute cystitis is one of the most commonly encountered bacterial infections and is responsible
for substantial morbidity and high medical costs in the United States and across the globe. …
for substantial morbidity and high medical costs in the United States and across the globe. …
Novel latency reversal agents for HIV-1 cure
AM Spivak, V Planelles - Annual review of medicine, 2018 - annualreviews.org
Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness; however, ART
is not curative owing to the persistence of replication-competent, latent proviruses in long-…
is not curative owing to the persistence of replication-competent, latent proviruses in long-…
Recommendations for measuring HIV reservoir size in cure-directed clinical trials
Therapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or
to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will …
to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will …
[HTML][HTML] No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019
Objective To describe detection of severe acute respiratory syndrome (SARS)–coronavirus
2 (CoV-2) in seminal fluid of patients recovering from coronavirus disease 2019 (COVID-19) …
2 (CoV-2) in seminal fluid of patients recovering from coronavirus disease 2019 (COVID-19) …
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1–infected adults on antiretroviral therapy
AM Spivak, A Andrade, E Eisele, R Hoh… - Clinical infectious …, 2014 - academic.oup.com
Background. Transcriptionally silent human immunodeficiency virus type 1 (HIV-1) DNA
persists in resting memory CD4 + T cells despite antiretroviral therapy. In a primary cell model, …
persists in resting memory CD4 + T cells despite antiretroviral therapy. In a primary cell model, …
[PDF][PDF] BIRC2/cIAP1 is a negative regulator of HIV-1 transcription and can be targeted by Smac mimetics to promote reversal of viral latency
L Pache, MS Dutra, AM Spivak, JM Marlett, JP Murry… - Cell host & …, 2015 - cell.com
Combination antiretroviral therapy (ART) is able to suppress HIV-1 replication to undetectable
levels. However, the persistence of latent viral reservoirs allows for a rebound of viral load …
levels. However, the persistence of latent viral reservoirs allows for a rebound of viral load …
[HTML][HTML] A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected
cells persist for decades on ART and viremia returns if ART is stopped. Persistence has …
cells persist for decades on ART and viremia returns if ART is stopped. Persistence has …
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
…, J Grau-Exposito, AM Spivak… - Science translational …, 2018 - science.org
… , AM Spivak). Total CD4 + T cells were purified via negative magnetic bead selection
using a total CD4 + T cell–negative isolation kit (STEMCELL) according to the manufacturer’s …
using a total CD4 + T cell–negative isolation kit (STEMCELL) according to the manufacturer’s …
HIV-1 eradication: early trials (and tribulations)
AM Spivak, V Planelles - Trends in molecular medicine, 2016 - cell.com
Antiretroviral therapy (ART) has rendered HIV-1 infection a manageable illness for those
with access to treatment. However, ART does not lead to viral eradication owing to the …
with access to treatment. However, ART does not lead to viral eradication owing to the …
Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4+ T Cells from Aviremic Patients
The human immunodeficiency virus type 1 (HIV-1) latent reservoir in resting CD4 + T cells
represents a major barrier to viral eradication. Small compounds capable of latency reversal …
represents a major barrier to viral eradication. Small compounds capable of latency reversal …